International journal of radiation oncology, biology, physics, 2008-05, Vol.71 (1), p.256-264
2008
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Individual Radiosensitivity Measured With Lymphocytes May Predict the Risk of Acute Reaction After Radiotherapy
- Ist Teil von
- International journal of radiation oncology, biology, physics, 2008-05, Vol.71 (1), p.256-264
- Ort / Verlag
- United States: Elsevier Inc
- Erscheinungsjahr
- 2008
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Purpose We tested whether the chromosomal radiosensitivity of in vitro irradiated lymphocytes could be used to predict the risk of acute reactions after radiotherapy. Methods and Materials Two prospective studies were performed: study A with 51 patients included different tumor sites and study B included 87 breast cancer patients. Acute reaction was assessed using the Radiation Therapy Oncology Group score. In both studies, patients were treated with curative radiotherapy, and the mean tumor dose applied was 55 Gy (40–65) ± boost with 11 Gy (6–31) in study A and 50.4 Gy ± boost with 10 Gy in study B. Individual radiosensitivity was determined with lymphocytes irradiated in vitro with X-ray doses of either 3 or 6 Gy and scoring the number of chromosomal deletions. Results Acute reactions displayed a typical spectrum with 57% in study A and 53% in study B showing an acute reaction of Grade 2–3. Individual radiosensitivity in both studies was characterized by a substantial variation and the fraction of patients with Grade 2–3 reaction was found to increase with increasing individual radiosensitivity measured at 6 Gy (study A, p = 0.238; study B, p = 0.023). For study B, this fraction increased with breast volume, and the impact of individual radiosensitivity on acute reaction was especially pronounced ( p = 0.00025) for lower breast volume. No such clear association with acute reaction was observed when individual radiosensitivity was assessed at 3 Gy. Conclusion Individual radiosensitivity determined at 6 Gy seems to be a good predictor for risk of acute effects after curative radiotherapy.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0360-3016eISSN: 1879-355XDOI: 10.1016/j.ijrobp.2008.01.007Titel-ID: cdi_osti_scitechconnect_21124208
- Format
- –
- Schlagworte
- Acute Disease, Acute reaction, Adult, Aged, Aged, 80 and over, Breast - pathology, Breast Neoplasms - pathology, Breast Neoplasms - radiotherapy, Breast volume, Carcinoma in Situ - pathology, Carcinoma in Situ - radiotherapy, Carcinoma, Ductal, Breast - pathology, Carcinoma, Ductal, Breast - radiotherapy, CARCINOMAS, Chromosomal radiosensitivity, Chromosome Deletion, Female, Hematology, Oncology and Palliative Medicine, Humans, IN VITRO, Individual radiosensitivity, IRRADIATION, LYMPHOCYTES, Lymphocytes - radiation effects, Male, MAMMARY GLANDS, Middle Aged, Neoplasms - pathology, Neoplasms - radiotherapy, PATIENTS, Prediction, Prospective Studies, RADIATION DOSES, Radiation Injuries - diagnosis, Radiation Injuries - genetics, Radiation Injuries - pathology, Radiation Tolerance - genetics, Radiology, RADIOLOGY AND NUCLEAR MEDICINE, RADIOSENSITIVITY, RADIOTHERAPY, Radiotherapy Dosage, Risk Assessment, X RADIATION